Placeholder text

Go to cart

Formulation and Optimization of Transdermal Patches

By Mukesh Rani

Formulation and Optimization of Transdermal Patches

By Mukesh Rani

0 - Default Title
Description
Lisinopril is an antihypertensive agent indicated for the prevention of hypertension, acute myocardial infarction and diabetic nephropathy. It is an angiotensin converting enzyme(ACE) inhibitor. It has a short half-life and undergoes variable first pass metabolism. It is required to be administered two or three times daily which results in poor patient compliance. In this work an attempt was made to formulate & evaluate TDDS for sustained release of lisinopril by solvent evaporation method. Low molecular weight, good permeability and shorter half-life of the drug made it a suitable candidate for the development of trans dermal patch.The main objective of formulating the transdermal system was to prolong the drug release time, reduce the frequency of administration and to improve patient compliance. The compatibility characterization was done by IR method. By using 32factorial design nine formulations were prepared using hydrophilic (HPMC) andhydrophobic (ethyl cellulose) polymers along with selected plasticizer & permeationenhancer. PVA backing membrane was used as a substrate for pouring the polymeric solution. The prepared patches were evaluated for physical appearance, thickness.
Product details
Binding:
Paperback
Number of Pages:
188
Release Date:
2025-08-11
Publication Date:
2025-08-11
Publisher:
LAP LAMBERT Academic Publishing
Languages:
Original: English
ISBN10:
6208427762
ISBN13:
9786208427764
GPSR Manufacturer Reference:
[email protected]
Weight:
298 g
Height:
150 cm
Width:
220 cm
Thickness:
12 cm
Buy on Amazon
Currently sold out